Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity.

Lopes JP, Tarozzo G, Reggiani A, Piomelli D, Cavalli A.

Brain Behav. 2013 Mar;3(2):67-74. doi: 10.1002/brb3.118. Epub 2013 Jan 11.

PMID:
23532860
[PubMed]
Free PMC Article
2.

Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor.

Hamouda AK, Kimm T, Cohen JB.

J Neurosci. 2013 Jan 9;33(2):485-94. doi: 10.1523/JNEUROSCI.3483-12.2013.

PMID:
23303929
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.

Kimmey BA, Rupprecht LE, Hayes MR, Schmidt HD.

Addict Biol. 2014 Jul;19(4):539-51. doi: 10.1111/adb.12014. Epub 2012 Dec 12.

PMID:
23231479
[PubMed - in process]
Free PMC Article
4.

Positive allosteric modulator of α7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates.

Callahan PM, Hutchings EJ, Kille NJ, Chapman JM, Terry AV Jr.

Neuropharmacology. 2013 Apr;67:201-12. doi: 10.1016/j.neuropharm.2012.10.019. Epub 2012 Nov 17.

PMID:
23168113
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The relationship between associative learning, transfer generalization, and homocysteine levels in mild cognitive impairment.

Moustafa AA, Hewedi DH, Eissa AM, Myers CE, Sadek HA.

PLoS One. 2012;7(9):e46496. doi: 10.1371/journal.pone.0046496. Epub 2012 Sep 28.

PMID:
23029537
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease.

Motel WC, Coop A, Cunningham CW.

Mini Rev Med Chem. 2013 Mar;13(3):456-66. Review.

PMID:
22931533
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Hopkins TJ, Rupprecht LE, Hayes MR, Blendy JA, Schmidt HD.

Neuropsychopharmacology. 2012 Sep;37(10):2310-21. doi: 10.1038/npp.2012.83. Epub 2012 Jun 6.

PMID:
22669169
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Specificity determinants of allosteric modulation in the neuronal nicotinic acetylcholine receptor: a fine line between inhibition and potentiation.

Cesa LC, Higgins CA, Sando SR, Kuo DW, Levandoski MM.

Mol Pharmacol. 2012 Feb;81(2):239-49. doi: 10.1124/mol.111.076059. Epub 2011 Nov 7.

PMID:
22064677
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Vascular cognitive impairment: disease mechanisms and therapeutic implications.

Levine DA, Langa KM.

Neurotherapeutics. 2011 Jul;8(3):361-73. doi: 10.1007/s13311-011-0047-z. Review.

PMID:
21556678
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.

Wilkinson DS, Gould TJ.

Behav Brain Res. 2011 Sep 30;223(1):53-7. doi: 10.1016/j.bbr.2011.04.010. Epub 2011 Apr 14.

PMID:
21514327
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptors.

Takata K, Kitamura Y, Saeki M, Terada M, Kagitani S, Kitamura R, Fujikawa Y, Maelicke A, Tomimoto H, Taniguchi T, Shimohama S.

J Biol Chem. 2010 Dec 17;285(51):40180-91. doi: 10.1074/jbc.M110.142356. Epub 2010 Oct 14.

PMID:
20947502
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pretreatment of Guinea pigs with galantamine prevents immediate and delayed effects of soman on inhibitory synaptic transmission in the hippocampus.

Alexandrova EA, Aracava Y, Pereira EF, Albuquerque EX.

J Pharmacol Exp Ther. 2010 Sep 1;334(3):1051-8. doi: 10.1124/jpet.110.167700. Epub 2010 Jun 16.

PMID:
20554906
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The positive allosteric modulator morantel binds at noncanonical subunit interfaces of neuronal nicotinic acetylcholine receptors.

Seo S, Henry JT, Lewis AH, Wang N, Levandoski MM.

J Neurosci. 2009 Jul 8;29(27):8734-42. doi: 10.1523/JNEUROSCI.1859-09.2009.

PMID:
19587280
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Morantel allosterically enhances channel gating of neuronal nicotinic acetylcholine alpha 3 beta 2 receptors.

Wu TY, Smith CM, Sine SM, Levandoski MM.

Mol Pharmacol. 2008 Aug;74(2):466-75. doi: 10.1124/mol.107.044388. Epub 2008 May 5.

PMID:
18458055
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia.

Dyer MA, Freudenreich O, Culhane MA, Pachas GN, Deckersbach T, Murphy E, Goff DC, Evins AE.

Schizophr Res. 2008 Jul;102(1-3):88-95. doi: 10.1016/j.schres.2007.12.491. Epub 2008 Mar 5.

PMID:
18325740
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia.

Buchanan RW, Freedman R, Javitt DC, Abi-Dargham A, Lieberman JA.

Schizophr Bull. 2007 Sep;33(5):1120-30. Epub 2007 Jul 19. Review.

PMID:
17641146
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.

Ferreri F, Agbokou C, Gauthier S.

J Psychiatry Neurosci. 2006 Nov;31(6):369-76. Review.

PMID:
17136214
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Modulation of neuronal nicotinic receptor function by the neuropeptides CGRP and substance P on autonomic nerve cells.

Di Angelantonio S, Giniatullin R, Costa V, Sokolova E, Nistri A.

Br J Pharmacol. 2003 Jul;139(6):1061-73. Review.

PMID:
12871824
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Current pharmacologic options for patients with Alzheimer's disease.

Reichman WE.

Ann Gen Hosp Psychiatry. 2003 Jan 29;2(1):1.

PMID:
12605726
[PubMed - as supplied by publisher]
Free PMC Article
20.

Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.

Capsoni S, Giannotta S, Cattaneo A.

Proc Natl Acad Sci U S A. 2002 Sep 17;99(19):12432-7. Epub 2002 Aug 30.

PMID:
12205295
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk